Women post breast mass biopsy with ER+ cancer will be randomized to two diets--45 of them to a ketogenic insulin inhibiting diet, 20 to a low fat diet simulating their existing diet, but with added fruits and vegetables. The initial biopsy will be evaluated along with the surgical specimen pathology to compare changes in biomarkers, particularly of proliferation (Ki-67) and apoptosis (TUNEL).